Babylon (NYSE:BBLN – Get Rating) had its target price boosted by BTIG Research to $20.00 in a report published on Thursday morning, The Fly reports. They currently have a buy rating on the stock.

A number of other equities analysts have also commented on the stock. Canaccord Genuity Group reduced their price target on shares of Babylon from $100.00 to $50.00 and set a buy rating on the stock in a research report on Friday, November 11th. Canaccord Genuity Group reduced their target price on shares of Babylon from $100.00 to $50.00 and set a buy rating on the stock in a research report on Friday, November 11th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Babylon presently has a consensus rating of Moderate Buy and an average target price of $81.43.

Babylon Stock Performance

NYSE:BBLN opened at $8.59 on Thursday. Babylon has a 12 month low of $6.31 and a 12 month high of $179.00. The company's 50-day moving average price is $11.23 and its two-hundred day moving average price is $16.21.

Institutional Investors Weigh In On Babylon

A number of institutional investors and hedge funds have recently modified their holdings of the business. Bank of New York Mellon Corp raised its stake in shares of Babylon by 14.5% during the third quarter. Bank of New York Mellon Corp now owns 208,624 shares of the company's stock worth $99,000 after buying an additional 26,449 shares during the last quarter. BNP Paribas Arbitrage SNC bought a new stake in shares of Babylon during the third quarter worth approximately $49,000. State Street Corp raised its stake in shares of Babylon by 22.5% during the third quarter. State Street Corp now owns 2,120,998 shares of the company's stock worth $1,002,000 after buying an additional 390,215 shares during the last quarter. Raymond James & Associates raised its stake in shares of Babylon by 64.4% during the third quarter. Raymond James & Associates now owns 125,033 shares of the company's stock worth $59,000 after buying an additional 49,000 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD bought a new stake in shares of Babylon during the second quarter worth approximately $2,903,000.

Babylon Company Profile

(Get Rating)

Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally.

Further Reading

• Get a free copy of the StockNews.com research report on Babylon (BBLN)
• Will LI Auto Be the Least Hated Chinese EV Stock in 2023?
• Here's Why Snap Stock Can Double in 2023
• Which Streaming Service Stock is Best in 2023?
• MarketBeat: Week in Review 01/02-01/06
• Why is the CrowdStrike Stock Price Struggling?

Receive News & Ratings for Babylon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Babylon and related companies with MarketBeat.com's FREE daily email newsletter.